Abstract:Objective To study the relative bioavailability and bioequivalence of two glipizide controlled -release preparations in healthy volunteers.Methods The tests were carried out according to single dosage regimen and multiple dosage regimen in a open crossover design. In single dosage regimen, 24 enrolled healthy volunteers were randomized given 5mg of test or reference preparation.In multiple dosage regimen,22 enrolled subjects were given 5 mg of test or reference preparation once daily for 7 consecutive days. LC-MS/MS was used to determine the glipizide concentration in serum. Pharmacokinetic parameters and relative bioavailability were calculated, and bioequivalence of the two preparations was evaluated.Results The main pharmacokinetic parameters were calculated as follows:In single dosage regimen, for reference and test preparations, t1/2β were (9.12±2.73), (8.60±4.43)h ;tmax were (10.67±5.13), (9.08±2.76)h;Cmax were (135.9 ±41.1),(157.9±25.3)ng·mL-1;AUC0-48 were (2852.0±946.6), (3021.5±899.9)ng·h·mL-1;AUC0-∞ were (3002.4±1107.6), (3167.6±1090.6) ng·h·mL-1 respectively. The relative bioavailability was (109.2 ±25.4)%.In multiple dosage regimen,for reference and test preparations, t1/2β were (11.31±3.37), (10.97±3.49 )h; tmax were (6.8 ±3.5), (6.6±3.7) h; Cssmax were (187.4±54.5), (176.0±72.3) ng·mL; Cssmin were (61.3 ±28.1), (69.1±41.2 )ng·mL; AUC0-48 were (3495.0 ±1110.6), (3488.2±1554.9)ng·h·mL-1;AUC0-∞ were (3670.7±1199.7), (3650.5±1599.2) ng·h·mL-1,respectively. The relative bioavailability was (101.0 ±32.1)%.DF were (56.2 ±19.9)%,(49.7±22.5)% for reference and test preparation,respectively.Conclusion The two preparations were bioequivalent.

Bioequivalence of Valaciclovir Hydrochlordide Tablets in Healthy Volunteers

Bioequivalence of Valaciclovir Capsules in Human

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Study of Relative Bioavailability of Aciclovir Tablet in Healthy Volunteers

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Studies on Bioequivalence of Indinavir Capsule in Healthy Volunteers

Bioequivalence Study of Voriconazole Tablet in Healthy Chinese Male Volunteers

Bioequivalence of Azithromycin Tablets in Healthy Volunteers

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Bioequivalence of Domestic Azithromycin Granules in Healthy Volunteers

Study on bioequivalence of pravastatin sodium tablets in healthy volunteers

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Bioequivalent Study of Citalopram Tablets

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Bioequivalence Test of Domestic Levetiracetam Tablets in Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Pharmacokinetic and Bioequivalence Evaluation of Single-Tablet and Separate-Tablet Regimens for Ainuovirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Chinese Healthy Subjects

Bioequivalence study of fluoxetine capsules in healthy volunteers

Bioequivalence of Levodopa Tablets in Healthy Volunteers

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers